wilsom disease

Reading File
Finding Sources
Searching Images

Wilson disease Kayser-Fleischer ring copper

This composite educational graphic illustrates clinical and diagnostic findings of the Kayser–Fleischer ring (KFR), a pathognomonic sign of Wilson disease. Panel A is a clinical photograph from a slit-lamp examination showing a diffuse, circumferential golden-brown pigment ring (black arrow) in the corneal limbic area. Panel B utilizes a fine-slit lamp beam to demonstrate the precise localization of copper deposits at the posterior aspect of the cornea (yellow arrow). Panel C provides a localized infrared corneal B-scan view, while Panel D presents an Anterior Segment Optical Coherence Tomography (AS-OCT) cross-sectional image. The AS-OCT scan reveals a distinct, linear hyper-reflective layer at the level of the Descemet’s membrane (yellow arrow), corresponding exactly to the clinical site of copper deposition. This visual comparison highlights how diagnostic imaging can verify clinical observations of ocular copper accumulation in patients with copper metabolism disorders.

This composite educational graphic illustrates clinical and diagnostic findings of the Kayser–Fleischer ring (KFR), a pathognomonic sign of Wilson disease. Panel A is a clinical photograph from a slit-lamp examination showing a diffuse, circumferential golden-brown pigment ring (black arrow) in the corneal limbic area. Panel B utilizes a fine-slit lamp beam to demonstrate the precise localization of copper deposits at the posterior aspect of the cornea (yellow arrow). Panel C provides a localized infrared corneal B-scan view, while Panel D presents an Anterior Segment Optical Coherence Tomography (AS-OCT) cross-sectional image. The AS-OCT scan reveals a distinct, linear hyper-reflective layer at the level of the Descemet’s membrane (yellow arrow), corresponding exactly to the clinical site of copper deposition. This visual comparison highlights how diagnostic imaging can verify clinical observations of ocular copper accumulation in patients with copper metabolism disorders.

A side-by-side clinical slit-lamp photograph comparing two types of corneal rings. Image (A) shows a Kayser-Fleischer (KF) ring in a patient with Wilson’s Disease, characterized by distinct copper-colored deposits located at the level of the Descemet's membrane in the inferior cornea. Image (B) demonstrates a Pseudo-Kayser-Fleischer (PKF) ring associated with hyperbilirubinemia, presenting as a faint yellow hue within the posterior stroma rather than the Descemet's membrane. Both images include anatomical labels for the epithelium, stroma, and Descemet's membrane to provide depth context. The comparison highlights the different anatomical localization and coloration of copper versus bilirubin deposits, which is a critical diagnostic distinction in patients presenting with liver disease and ocular findings.

A side-by-side clinical slit-lamp photograph comparing two types of corneal rings. Image (A) shows a Kayser-Fleischer (KF) ring in a patient with Wilson’s Disease, characterized by distinct copper-colored deposits located at the level of the Descemet's membrane in the inferior cornea. Image (B) demonstrates a Pseudo-Kayser-Fleischer (PKF) ring associated with hyperbilirubinemia, presenting as a faint yellow hue within the posterior stroma rather than the Descemet's membrane. Both images include anatomical labels for the epithelium, stroma, and Descemet's membrane to provide depth context. The comparison highlights the different anatomical localization and coloration of copper versus bilirubin deposits, which is a critical diagnostic distinction in patients presenting with liver disease and ocular findings.

This composite figure illustrates the clinical and radiological hallmarks of Wilson's disease. The top-left clinical photograph shows a close-up of an eye with a yellow arrow pointing to a Kayser-Fleischer ring, characterized by a brownish-gold copper deposition at the corneal limbus. The top-right photograph depicts a patient with a 'mask-like facies' (hypomimia), noted by arrows pointing toward the mouth and facial muscles. The bottom panels consist of two axial MRI brain images (T2-weighted/FLAIR sequences). Yellow arrows indicate bilateral, symmetrical hyperintensities within the basal ganglia, specifically involving the lentiform nuclei (globus pallidus and putamen) and the thalami. These findings are highly characteristic of copper accumulation in the central nervous system and are critical for the diagnostic evaluation of hepatolenticular degeneration. The visual evidence correlates with neurological manifestations such as tremors and spasticity in pediatric or young adult patients.

This composite figure illustrates the clinical and radiological hallmarks of Wilson's disease. The top-left clinical photograph shows a close-up of an eye with a yellow arrow pointing to a Kayser-Fleischer ring, characterized by a brownish-gold copper deposition at the corneal limbus. The top-right photograph depicts a patient with a 'mask-like facies' (hypomimia), noted by arrows pointing toward the mouth and facial muscles. The bottom panels consist of two axial MRI brain images (T2-weighted/FLAIR sequences). Yellow arrows indicate bilateral, symmetrical hyperintensities within the basal ganglia, specifically involving the lentiform nuclei (globus pallidus and putamen) and the thalami. These findings are highly characteristic of copper accumulation in the central nervous system and are critical for the diagnostic evaluation of hepatolenticular degeneration. The visual evidence correlates with neurological manifestations such as tremors and spasticity in pediatric or young adult patients.

This clinical photograph shows a close-up slit-lamp examination of the eye, specifically focusing on the anterior segment and cornea. A prominent Kayser-Fleischer ring is visible as a golden-brown or greenish-yellow circumferential band located at the corneal periphery. This pigment deposition occurs within Descemet's membrane near the limbus. The slit-lamp beam provides cross-sectional illumination, highlighting the depth of the copper deposition and the relative transparency of the central corneal stroma. Subtle limbal vascularization is observed in the peripheral sclera. This finding is a pathognomonic sign of Wilson's disease (hepatolenticular degeneration), reflecting systemic copper overload and abnormal metabolism of ceruloplasmin. The image serves as a high-yield diagnostic reference for ophthalmology and internal medicine, illustrating the classic ocular manifestation of this metabolic disorder.

This clinical photograph shows a close-up slit-lamp examination of the eye, specifically focusing on the anterior segment and cornea. A prominent Kayser-Fleischer ring is visible as a golden-brown or greenish-yellow circumferential band located at the corneal periphery. This pigment deposition occurs within Descemet's membrane near the limbus. The slit-lamp beam provides cross-sectional illumination, highlighting the depth of the copper deposition and the relative transparency of the central corneal stroma. Subtle limbal vascularization is observed in the peripheral sclera. This finding is a pathognomonic sign of Wilson's disease (hepatolenticular degeneration), reflecting systemic copper overload and abnormal metabolism of ceruloplasmin. The image serves as a high-yield diagnostic reference for ophthalmology and internal medicine, illustrating the classic ocular manifestation of this metabolic disorder.

Searching PubMed

"Wilson disease"[MeSH Terms] AND treatment

Reading File
Reading File
Reading File
Loading Image
Reading File
I now have comprehensive information from multiple authoritative textbooks. Here is a full, well-organized answer on Wilson disease:

Wilson Disease (Hepatolenticular Degeneration)

Genetics & Pathophysiology

Wilson disease is an autosomal recessive disorder caused by loss-of-function mutations in the ATP7B gene (chromosome 13). ATP7B encodes a copper-transporting transmembrane ATPase located in the trans-Golgi network (TGN) and lysosomes of hepatocytes. It has two critical functions:
  1. In the TGN: Incorporates copper into apoceruloplasmin to form ceruloplasmin, which is secreted into blood.
  2. In lysosomes: Transports non-ceruloplasmin-bound copper into bile canaliculi for excretion (the major route of copper elimination).
In Wilson disease, both pathways fail, so copper accumulates in hepatocytes, generating reactive oxygen species (ROS) and causing cell injury. As the liver becomes overwhelmed, free non-ceruloplasmin-bound copper spills into the bloodstream, causing hemolysis and depositing in the brain, corneas, kidneys, bones, joints, and parathyroid glands.
Copper metabolism and ATP7B mutation in Wilson disease
Copper metabolism and the consequences of ATP7B mutation. In Wilson disease, copper cannot be incorporated into ceruloplasmin or excreted into bile, leading to hepatocyte accumulation and eventual systemic release. - Robbins & Kumar Basic Pathology

Clinical Features

Symptoms usually appear between 6 and 40 years of age, though onset as late as the 5th-6th decade is reported. Presentation falls into three roughly equal groups:

1. Hepatic Disease (~1/3 of cases)

  • Ranges from mild steatosis and focal necrosis to chronic hepatitis, cirrhosis, or acute fulminant liver failure (ALF)
  • In ALF, key clues: ALP:bilirubin ratio <4 and AST:ALT ratio >2.2 (distinguishes Wilson ALF from other causes)
  • Ascites is an early feature in the acute presentation, typically in the second decade

2. Neurological Disease (~1/3 of cases)

  • Predominantly extrapyramidal: chorea, tremor (sometimes "wing-beating"), dystonia
  • Also: dysphagia, dysarthria, ataxia, gait disturbance, a fixed sardonic smile
  • MRI shows abnormal T2/FLAIR signal in the putamen, thalamus, midbrain, pons, cerebellum; atrophy is common

3. Neuropsychiatric Disease (~1/3 of cases)

  • Personality and mood changes are the most common early features
  • Depression in ~30%, bipolar spectrum ~20%, suicidal ideation in 5-15%
  • Patients can be unusually sensitive to neuroleptics
  • Despite long-term treatment, ~70% of patients develop psychiatric symptoms

Characteristic Sign: Kayser-Fleischer Rings

Kayser-Fleischer (KF) rings are green-to-brown deposits of copper in Descemet membrane at the limbus of the cornea. They are:
  • Present in ~98% of patients with neurological disease
  • Present in ~80% of all Wilson disease cases
  • Best visualized with slit-lamp examination
  • Must be distinguished from pseudo-KF rings (due to hyperbilirubinemia, which deposits in the stroma rather than Descemet membrane)
Kayser-Fleischer ring on slit-lamp examination - classic golden-brown copper deposits at Descemet's membrane in Wilson disease
Composite showing KF ring, mask-like facies, and bilateral basal ganglia T2 hyperintensities on MRI in Wilson disease

Morphology (Pathology)

OrganFindings
LiverSteatosis, focal necrosis, chronic hepatitis, steatohepatitis (ballooning + Mallory hyaline), cirrhosis; copper stain (rhodanine/orcein) shows red-brown lysosomal deposits
BrainToxic injury to basal ganglia (putamen/lenticular nuclei), thalamus; T2 hyperintensities on MRI
CorneaKF rings at Descemet membrane
KidneyRenal tubular dysfunction (Fanconi syndrome)
Bones/JointsOsteoporosis, arthropathy

Diagnosis

TestFindingNotes
Serum ceruloplasminLowHallmark, but doesn't cause pathology
24-hr urinary copperElevatedMost specific test
Hepatic copper content>250 µg/g dry weightMost sensitive test (~80%)
Slit-lamp examKF ringsEssential in neurological cases
Liver biopsySteatosis, hepatitis, copper depositsSometimes necessary
MRI brainT2 hyperintensity in basal gangliaIn neurological disease
Serum copperLow, normal, or elevatedNot diagnostically useful
Note: Genetic testing is complicated by the very large number of different ATP7B mutations (unlike hemochromatosis, where a few common variants suffice).

Treatment

TherapyMechanismUse
D-penicillamineCopper chelationFirst-line; 20-50% of neurological patients worsen acutely
TrientineCopper chelationLower risk of neurological worsening; preferred if penicillamine not tolerated
TetrathiomolybdateCopper chelationMay have the lowest neurological worsening risk
Zinc saltsBlocks intestinal copper absorption (induces metallothionein in enterocytes)Presymptomatic patients, maintenance therapy, pregnancy
Liver transplantationCurative (restores ATP7B function)Advanced cirrhosis, fulminant hepatic failure
Early recognition and long-term treatment have dramatically altered the previously progressive course. Early treatment may partially reverse MRI changes and most neurological/psychiatric symptoms.

Key Points for Exam

  • Gene: ATP7B (chromosome 13) - autosomal recessive
  • Inheritance: 1 in 30,000-40,000 live births
  • KF rings are pathognomonic when combined with neurological disease (absent in ~20% of all cases)
  • Low ceruloplasmin + elevated 24-hr urine copper + elevated hepatic copper = diagnosis
  • ALF clue: ALP/bilirubin <4 and AST/ALT >2.2
  • Penicillamine can cause paradoxical neurological worsening - trientine is preferred in such cases
  • Liver transplantation is curative because it replaces the defective ATP7B-expressing hepatocytes
Sources: Robbins & Kumar Basic Pathology; Bradley and Daroff's Neurology in Clinical Practice; Sleisenger and Fordtran's Gastrointestinal and Liver Disease
This is a shared conversation. Sign in to Orris to start your own chat.